Hope rises for cancer treatment as key drug gets U.S. approval

Hope rises for cancer treatment as key drug gets U.S. approval

Sharing is caring!Facebook1Twitter0Google+0Pinterest0The U.S. Food and Drug Administration (FDA) on Wednesday granted breakthrough therapy designation...

Nigerian porn king, Kingtblakhoc reveals how much he pays Nigerian girls for porn (18+)
Beyonce’s twins were born premature and are being kept ‘under the lights’
Pres. Buhari’s visit to Bauchi state postponed due to bad weather

Sharing is caring!

The U.S. Food and Drug Administration (FDA) on Wednesday granted breakthrough therapy designation to drug maker, AstraZeneca’s biggest new drug hope Durvalumab for the treatment in bladder cancer.

The experimental medicine is a “PD-L1’’ therapy that fights cancer by boosting the immune system.

The breakthrough therapy designation expedites the development and review of medicines intended to treat serious or life-threatening diseases.

The drug, Durvalumab, is also being developed as a treatment for lung, head and neck, gastric, pancreatic, liver and blood cancers.

The drug is competing with rival products made by Bristol-Myers Squibb, Merck and Roche.

(Reuters/NAN)

(Visited 74 times, 1 visits today)

Comments

comments

COMMENTS

WORDPRESS: 0
DISQUS: 0